<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Nat Cell Biol. 2009 December ; 11(12): 1444. doi:10.1038/ncb1993. <br />  <br />  <br />  <br />                            YAP-dependent induction amphiregulin identifies non-cell- <br />                            autonomous component Hippo pathway <br />  <br />                            Jianmin Zhang1, Jun-Yuan Ji1, Min Yu1,2, Michael Overholtzer3, Gromoslaw  Smolen1, <br />                            Rebecca Wang1, Joan S. Brugge3, Nicholas J. Dyson1, Daniel  Haber1,2,* <br />                            1 Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129 <br />  <br />                            2   Howard Hughes Medical Institute, Harvard Medical School, Boston MA 02115 <br />                            3   Department Cell Biology, Harvard Medical School, Boston MA 02115 <br />  <br />                            Abstract <br />                                  Hippo signaling pathway regulates cellular proliferation survival, exerting profound <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  effects normal cell fate tumorigenesis1-3. pivotal effector pathway YAP,                                  transcriptional activator amplified mouse human cancers, promotes epithelial                                  mesenchymal transition (EMT) malignant transformation4-10. <span id='am-1' about='oboInOwl:date' typeof='owl:Thing'>date</span>, studies YAP target <br />                                  genes focused cell-autonomous mediators; YAP-expressing MCF10A <br />                                  breast epithelial cells enhance proliferation neighboring untransfected cells, implicating non- <br />                                  cell autonomous mechanism. identify epidermal growth factor receptor (EGFR) ligand, <br />                                  amphiregulin (AREG), transcriptional target YAP, induction contributes YAP- <br />                                  mediated cell proliferation migration, EMT. Knockdown AREG addition                                  EGFR kinase inhibitor abrogates proliferative effects YAP expression. Suppression                                  negative YAP regulators LATS1/2 sufficient induce AREG expression, consistent                                  physiological regulation AREG Hippo pathway. Genetic interaction                                  Drosophila YAP orthologue Yorkie Egfr signaling components support link                                  highly conserved signaling pathways.  YAP-dependent secretion AREG implicates <br />                                  activation EGFR signaling important non-cell autonomous effector Hippo pathway, <br />                                  implications regulation physiological malignant cell proliferation. <br />  <br />                                             Normal cells require mitogenic growth signals proliferate,  tumor cells                                             generate proliferative signals secretion growth factors activation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             growth factor receptors 11. shown YAP transduced MCF10A cells proliferate <br />                                             3D acinar cultures absence EGF 7. MCF10A immortalized, non transformed <br />                                             human mammary epithelial cells, exhibit dependence growth factors proliferation <br />                                             survival 12, raising possibility YAP itself induces secretion required growth <br />                                             factors cytokines cells. test hypothesis, performed mixing experiments <br />                                             cells transduced GFP-labeled YAP Red-Cherry tagged vector. MCF10A <br />                                             cells expressing GFP-YAP, Cherry-vector, formed acini 3D cultures absence <br />                                             exogenous EGF. Remarkably, vector transduced cells did produce acini cultured                                             1:1 ratio YAP expressing cells (Fig. 1a).  ectopic expression YAP MCF10A <br />                                             cells appears result secretion factors enable proliferation neighboring <br />                                             untransduced cells. <br />  <br />  <br />  <br />  <br />                             correspondence addressed: MGH Cancer Center, Bldg. 149, 13th Street, Charlestown, MA 02129; Tel (617) <br />                            726-7805; Fax: (617) 724-6919; haber@helix.mgh.harvard.edu. <br />                             Zhang et al.                                                                                          Page 2 <br />  <br />  <br />                                           identify mediators apparent YAP-induced non-cell-autonomous effect, use <br />                                           constitutively active YAP mutant, YAP-S127A. Mutation serine residue targeted <br />                                           phosphorylation negative regulatory kinases LATS1/2 prevents cytoplasmic <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           sequestration YAP 14-3-3 proteins 5,10, resulting exclusively nuclear <br />                                           localization (Fig. S1a). Retroviral vectors containing wild type YAP YAP-S127A induced <br />                                           similar levels protein expression (Fig. 1b). Ectopic expression YAP-S127A induced                                           strong EMT cell migration phenotype (Fig. S1b S1c), robustly promoted EGF- <br />                                           independent acinar growth MCF10A 3D-cultures (Fig. 1b). enhanced YAP phenotype <br />                                           displayed YAP-S127A led increased effect culturing experiments,                                           YAP-S127A expressing MCF10A cells, dramatically stimulating acini formation                                           neighboring vector-transfected cells (Fig. 1a). test YAP-expressing cells <br />                                           release growth-inducing factors, collected conditioned medium 3D cultures                                           applied parental MCF10A cells 3D culture assays. Conditioned media derived                                           cells transduced wild type YAP (YAP-Wt), greater extent YAP-S127A <br />                                           vector, enabled MCF10A acinus formation absence EGF (Fig. 1c), supporting <br />                                           existence diffusible factor mediating non-cell autonomous effect. <br />  <br />                                           identify putative factors secreted YAP-expressing MCF10A cells, applied <br />                                           conditioned media Cytokine Antibody Array (RayBiotech&#226;&#8222;&#162;) representing 41 growth <br />                                           factors cytokines 13. media collected cells grown standard 3D growth <br />                                           conditions (including EGF supplementation, allowing acinus formation parental MCF10A <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           cells), significant differences observed vector YAP-S127A transduced <br />                                           cells (Fig. 2a).  conditioned media collected cultures absence                                           EGF supplementation revealed proteins highly enriched (3-fold                                           background) YAP-S127A transduced cells: amphiregulin (AREG), insulin-like growth <br />                                           factor binding protein -6 (IGFBP-6), platelet-derived growth factor -AA (PDGF-AA)                                           macrophage colony-stimulating factor-receptor (M-CSF-R) (Fig. 2a). test                                           proteins specifically induced YAP, byproducts 3D acini formation.                                           analyzed vector versus YAP-S127A expressing MCF10A cells grown 2D monolayer <br />                                           cultures following withdrawal EGF (12 hrs). observed AREG dramatically <br />                                           induced YAP-S127A cells determined immunoblotting analysis (Fig. 2b). AREG                                           constitutes primary candidate YAP-induced secreted factor involved cellular <br />                                           proliferation. <br />  <br />                                           test AREG transcriptional target YAP, measured AREG mRNA                                           YAP transduced cells. fold increase AREG transcript observed YAP- <br />                                           S127A transduced cells cultured absence EGF (Fig. 2c). Binding YAP AREG <br />                                           promoter vivo demonstrated chromatin immunoprecipitation (ChIP) assays. Anti- <br />                                           YAP- immunoprecipited chromatin yielded strong reproducible PCR amplification NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           fragment AREG promoter (Fig. 2d), comparable observed CTGF <br />                                           promoter, known YAP target gene 9,14. <br />  <br />                                           Given identification AREG transcriptional target YAP, undertook series                                           experiments test functional consequences interaction. tested                                           neutralizing antibodies AREG suppressed YAP-mediated 3D acini formation. Addition <br />                                           1&#206;&#188;g/ml anti-AREG IgG suppressed acini formation YAP-S127A cells 90%,                                           blocking antibodies IGFBP6, PDGF-AA M-CSF-R effect (Fig. 2e). AREG <br />                                           contributes YAP-mediated proliferation assay. test AREG                                           sufficient mediate 3D growth MCF10A cells, added recombinant AREG                                           cultures parental MCF10A cells. dose-dependent effect AREG evident, equivalent <br />                                           EGF generating 3D acini (Fig. 3a). <br />  <br />  <br />  <br />  <br />                                                 Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                            Page 3 <br />  <br />  <br />                                           determine YAP-induced secretion AREG associated increased ErbB <br />                                           receptor family signaling, applied lysate YAP-S127A transduced cells EGFR <br />                                           Phosphorylation Antibody Array (RayBiotech&#226;&#8222;&#162;). presence exogenous EGF, 17 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           ErbB phosphorylation sites interrogated array comparable vector                                           YAP-S127A transduced cells (Fig. 3b).  absence EGF, cellular lysates                                           YAP-S127A transduced cells displayed significantly increased phosphorylation classical <br />                                           EGFR target residues, EGFR-Y845, Y1068 Y1148, select residues                                           ErbB-2, ErbB-3 ErbB-4 (Fig. 3b). note, EGFR activation AREG cell types <br />                                           reported involve autocrine loop culminating EGFR-dependent AREG <br />                                           induction 15. exclude mechanism, measured AREG levels presence                                           absence erlotinib, specific kinase inhibitor EGFR. Efficient inhibition EGFR <br />                                           signaling effect YAP-mediated AREG induction (Fig. 3c 3d).  AREG <br />                                           induction YAP appears result direct transcriptional mechanism                                           EGFR-dependent feedback loop. Erlotinib treatment completely abrogated 3D acini <br />                                           formation YAP-S127A transduced cells (Fig. 3e), supporting key role EGFR <br />                                           signaling YAP-mediated proliferation. <br />  <br />                                           Ectopic overexpression YAP mimics effect gene amplification cancer.  <br />                                           model physiological activation Hippo pathway, use ACHN kidney cancer <br />                                           cells, homozygous deletion upstream negative regulator Salvador, leads                                           elevated endogenous YAP activity 5,10,16. Knockdown YAP cells led significant <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           reduction baseline AREG expression (Fig. 3f). YAP activity inhibited upstream <br />                                           kinases LATS1/2, mediate cytoplasmic retention YAP 5,6,10. test                                           physiological activation YAP abrogation LATS1/2 leads induction AREG, <br />                                           knocked LATS1/2 transcripts MCF10A cells. Dramatic induction AREG <br />                                           expression evident following suppression LATS1/2 cells (Fig. 3h). Taken <br />                                            observations demonstrate regulation endogenous AREG expression YAP <br />                                           induction disruption multiple levels Hippo pathway. <br />  <br />                                           test contribution AREG induction various YAP-mediated phenotypes,                                           use lentiviral shRNA-mediated knockdown constructs targeting AREG itself. addition                                           3D acini formation, YAP-dependent phenotypes MCF10A cells include induction                                           EMT increased cellular migration. Efficient knockdown baseline YAP-S127A <br />                                           induced AREG expression  precursor cleaved AREG) accomplished using                                           independent AREG-targeting constructs (Fig. 4a). YAP-induced phosphorylation                                           downstream signaling molecules AKT ERK effectively suppressed AREG <br />                                           knockdown, demonstrating disruption autocrine pathway cells (Fig. 4a).                                           expected, AREG-targeting constructs dramatically inhibited EGF-independent 3D <br />                                           acini formation (Fig. 4b). addition, suppression AREG dramatically inhibited cell <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           migration induced YAP-Wt YAP-S127A (Fig. 4c). contrast, knockdown                                           AREG effect expression EMT-related markers (Fig. 4d), suggesting AREG <br />                                           contribute distinct YAP-dependent effect. <br />  <br />                                           Connective tissue growth factor (CTGF) recently identified transcriptional target <br />                                           YAP transcription factor TEAD, contributing YAP-mediated EMT 14. <br />                                           test CTGF plays role YAP-dependent non-cell-autonomous effect studied <br />                                            targeted CTGF expression YAP-transduced MCF10A cells using independent <br />                                           lentiviral shRNA constructs. Efficient knockdown CTGF accomplished,                                           effect YAP-mediated acini formation (Fig. S 2a 2b).  CTGF AREG                                           serve complementary effectors YAP, mediating distinct downstream phenotypes. <br />  <br />                                           complex Hippo pathway shows high degree evolutionary conservation                                           Drosophila, uncovered mammals. Despite fact components  <br />  <br />                                                 Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                                 Page 4 <br />  <br />  <br />                                           pathway leading activation mammalian YAP Drosophila yki highly conserved <br />                                           1,2, downstream effectors yki identified date Drosophila screens                                           appear similarly regulated mammalian cells 5,9. asked NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           relevant components EGFR pathway interact genetically core factors                                           Drosophila Hippo pathway. <br />  <br />                                           EGFR signaling Drosophila involves receptor (Egfr) Egfr ligands: Spitz, Keren, <br />                                           Gurken Vein 17. test genetic interactions, crossed flies carrying mutations <br />                                           EGFR, EGFR ligands, EGFR processing proteins 17 flies harboring mutations                                           Hippo pathway, including warts (wts Hippo (Hpo), negative regulators yki,                                           expressed control eye-specific promoter (GMR). Consistent                                           previous report 16, GMR-wts eyes normal appearance (Fig. 5b) compared wild- <br />                                           type (Fig 5a). rough eye phenotype evident GMR-wts combined                                           heterozygous loss function mutation Egfr itself does phenotype (Fig. <br />                                           5c). similar synthetic interaction observed GMR-wts combined                                           loss function alleles Egfr (Table S1), mutant allele vein,                                           EGFR ligand (Fig. 5d). contrast, mutant alleles EGFR ligands, spitz, <br />                                           keren gurken, produced synergistic effect (Table S1). carried second set                                           genetic tests combining GMR-hpo EGFR pathway components. Unlike GMR-wts,                                           eye-specific overexpression Hippo (hpo) generates small, rough eye phenotype,                                           regular ommatidial organization disrupted individual ommatidia NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           distinguished 18 (Fig. 5e). combined heterozygous mutations Egfr (Fig. 5f)                                           vein (Fig. 5g), ommatidial organization severely disrupted: eyes glassy <br />                                           appearance fused ommatidia apparent (Fig. 5f, g), suggesting mutant alleles                                           Egfr vein dominantly enhanced GMR-hpo rough-eye phenotype. contrast, mutant <br />                                           alleles spitz, keren, gurken hadnosucheffect (Table S1). set genetic analyses, <br />                                           used previously reported GMR-yki phenotype 19 (Fig. S 3b), causes bulgy, <br />                                           rough eye phenotype (GMR-yki). yki overgrowth phenotype partially suppressed                                           heterozygous loss function alleles Egfr (Fig. S 3c).  partial suppression                                           phenotype observed mutant alleles vein, EGFR ligands, <br />                                           e., spitz, keren, gurken (Table S1). Taken  genetic crosses indicate                                           increased activity Drosophila YAP ortholog yki partially suppressed Egfr <br />                                           pathway mutants, reduced activity yki pathway resulting overexpression                                           negative regulators wts hpo enhanced loss function Egfr pathway. <br />  <br />                                           investigate molecular mechanisms Hpo Egfr signaling pathways <br />                                           interact Drosophila, measured phospho-ERK activity immunoblotting wing <br />                                           imaginal discs ectopically expressing constitutively active form human YAPS127A <br />                                           (genotype: w; nubbin-Gal4/UAS-YAPS127A; +). Increased phospho-ERK levels observed <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           YAPS127A wing discs (Fig. 5h), consistent activation Egfr signaling. <br />  <br />                                           determine Egfr ligands induced Drosophila Yki, tested                                           expression using qRT-PCR eye discs ectopically expressing constitutively active form <br />                                           Yki (YkiS168A, equivalent YAPS127A, Huang et al., 2005) (genotype: yw eyFlp/+; tub&gt;y <br />                                           +&gt;ykiS168A/+). Egfr ligands, vein displayed moderate, reproducible increased <br />                                           expression yki activated clones (Fig. 5i). selective effect Egfr ligand                                           particularly interesting consistent genetic interactions yki Egfr <br />                                           pathways described  genetic studies implicated vein, ligands, <br />                                           modifier Hippo phenotypes (Table S1). Taken  results suggest <br />                                           interactions Hippo Egfr pathways Drosophila compatible                                           functional relationship identified mammalian cells. genetic interactions                                           complex, studies necessary determine vein expression directly <br />                                           regulated Yki, altered indirectly.  results suggest selective <br />  <br />  <br />                                                 Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                              Page 5 <br />  <br />  <br />                                           induction Egfr ligand Yki contribute interplay Egfr Hippo <br />                                           pathways Drosophila. Unlike mammalian cells, YAP effectors implicated <br />                                           cell autonomous pathways, secreted ligands linked Drosophila Hippo <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           pathway. Yki activation leads activation Wingless, ligand Wnt pathway                                           Serrate, ligand Notch pathway 20,21. Loss upstream Hippo component fat                                           results activation Egfr signaling 22. Activation Egfr signaling AREG secretion <br />                                           mammalian cells represent evolutionarily conserved feature Hippo <br />                                           pathway. <br />  <br />                                           summary, EGFR ligand AREG appears downstream effector Hippo <br />                                           pathway direct target YAP. role YAP mammalian systems                                           established tumorigenesis studies, recently linked regulation                                           progenitor cell pools organ size liver regeneration 4,5.  YAP target genes <br />                                           play important roles physiological malignant proliferation signals. YAP target <br />                                           genes investigated gene expression profiling MCF10A cells mouse <br />                                           5,6,9,14. Interestingly, AREG potential targets listed screens MCF10A <br />                                           cells. YAP mediated transcriptional induction thought involve binding known <br />                                           transcription factors, including p73, Runx2 TEAD family members 1,2,23. Chip <br />                                           experiments unable identify binding sites transcription factors AREG <br />                                           promoter (data shown), pointing potential additional transcriptional partners YAP                                           mediating AREG induction. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Like YAP, AREG overexpression implicated normal organ proliferation                                           malignancy. addition secretion cancer cell lines 24-26, AREG mediates <br />                                           protection liver injury mouse model 27, breast, key mediator                                           estrogen-induced pubertal epithelial morphogenesis. Mouse knockouts estrogen receptor <br />                                           alpha, AREG EGFR display similar defects mammary gland development 28.  <br />                                           breast potentially tissues, AREG mediate developmentally regulated <br />                                           proliferation malignant transformation, consistent contribution broad role <br />                                           YAP Hippo pathway regulation cellular homeostasis. fact YAP <br />                                           mediate key functions secreted growth factor implicates non-cell <br />                                           autonomous mechanism contribute expansion normal malignant <br />                                           progenitors, raising possibility eventual therapeutic applications. <br />  <br />                               METHODS <br />                               Cell Culture Transfections <br />                                           MCF10A cell culture 3D culture performed described 29. ACHN cells                                           maintained Dulbecco&apos;s Modified Eagle Medium (DMEM) supplemented 10% fetal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           bovine serum, 2 mM <span id='am-14' about='obo:IMR_0200448' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00064" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="L-Glutamine" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:id" content="IMR:0200448" datatype="xsd:string"></span>L-glutamine</span>, 50 U/ml penicillin/streptomycin incubated 5% <br />                                           <span id='am-9' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-10' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="CO2" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span>CO2</span> 37 &#194;&#176;C. Transwell cell migration assay performed previously described 7. <br />  <br />                                           knockdown studies, shRNA hairpins targeting human YAP AREG obtained                                           RNAi Consortium (Broad Institute). Forward oligo sequences listed  5&#226;&#8364;&#178;-3&#226;&#8364;&#178; <br />                                           direction): shYAP  <br />                                           CCGGCCCAGTTAAATGTTCACCAATCTCGAGATTGGTGAACATTTAACTGGGTTT <br />                                           TTG; shYAP-B: <br />                                           CCGGGCCACCAAGCTAGATAAAGAACTCGAGTTCTTTATCTAGCTTGGTGGCTT <br />                                           TTTG. shAREG-A9: <br />                                           CCGGCACTGCCAAGTCATAGCCATACTCGAGTATGGCTATGACTTGGCAGTGTT <br />                                           TTTG; shAREG- <br />                                           G12:CCGGGAACGAAAGAAACTTCGACAACTCGAGTTGTCGAAGTTTCTTTCGTT <br />                                           CTTTTTG. Control shRNA: <br />  <br />  <br />                                                 Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                        Page 6 <br />  <br />  <br />                                           CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTCATCTTGTTGTT <br />                                           TTT. shCTGF-1 shCTGF-2 previously reported 14. Lentivirus packaging, MCF10A <br />                                           cell transduction drug selection performed following standard protocols. Human YAP <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           expression construct described previously 7; YAP-S127A expression construct                                           synthesized PCR-based mutagenesis. siRNA experiments performed described 9. <br />                                           siRNA duplex  TARGETplus-SMARTpool) targeting human LATS1(L-004632-00), <br />                                           LATS2 (L-003865-00) non-targeting control (D-001810-10) purchased                                           Dharmacon RNAi Technologies. <br />  <br />                                           conditioned medium treatment, vector, YAP-Wt YAP-S127A transduced MCF10A cells <br />                                           grown 3D culture absence EGF. Media collected added MCF10A <br />                                           parental cells 3D culture 4 days. <br />  <br />                               Antibodies Molecular Analyses <br />                                           Phospho-AKT (Ser-473), phospho-p44/42 MAP kinase (Thr202/Tyr204), total AKT, ERK, <br />                                           YAP (phospho-S127) antibodies purchased Cell Signaling Technology <br />                                           (Beverly, MA); Phospho-EGFR (Y1068) antibody Biosource (Camarillo, CA); YAP, <br />                                           EGFR antibodies Santa Cruz biotechnology (Santa Cruz, CA); LATS1 LATS2 <br />                                           antibodies Bethyl (Montgomery TX); &#206;&#178;-Tubulin antibody upstate (Lake Placid, <br />                                           NY); Flag (M2) antibody Sigma (St. Louis, MO); hAREG, hIGFBP-6, hPDGF-AA, hM- <br />                                           CSF R control IgG neutralizing antibodies purchased R <span id='am-2' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-3' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-7' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amp</span>; D systems <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (Minneapolis, MN). Western blot analysis, cells washed phosphate-buffered <br />                                           saline collected IP buffer: 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 20% glycerol, <br />                                           0.5% NP-40, 1x protease inhibitor cocktail (Complete&#226;&#8222;&#162; EDTA-free, Roche). Cell lysate                                           cleared centrifugation 14,000 rpm 20 min 4 &#194;&#176;C. Lysate loaded 4-15% <br />                                           SDS-PAGE gel (ReadyGel, Bio-Rad) 2X SDS sample buffer. immunoblotting <br />                                           analysis, proteins transferred Immobilon PVDF (Millipore), detected various <br />                                           antibodies visualized Western Lightning Plus Chemiluminescence Kit (Perkin <br />                                           Elmer). Human Cytokine Antibody Array Human EGFR Phosphorylation Antibody <br />                                           Array analyses performed according user manual (RayBiotech, Norcross, GA). <br />  <br />                                           RNA preparation qRT-PCR detection, RNA extracted using RNeasy Mini Kit <br />                                           (Qiagen). cDNA synthesis performed using Strand cDNA Synthesis Kit (GE <br />                                           Healthcare) quantitative real-time PCR performed using Power SYBR Green PCR <br />                                           Master Mix (Applied Biosystems). <br />  <br />                                           Sequences qPCR primer pairs  5&#226;&#8364;&#178;-3&#226;&#8364;&#178; direction) follows: GAPDH-F: <br />                                           GGTGAAGGTCGGAGTCAACGG; GAPDH-R: GAGGTCAATGAAGGGGTCATTG; <br />                                           YAP-F: CCTTCTTCAAGCCGCCGGAG; YAP-R: CAGTGTCCCAGGAGAAACAGC; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           AREG-F: CGAACCACAAATACCTGGCTA; AREG-R: TCCATTTTTGCCTCCCTTTT; <br />                                           IGFBP6-F: CACTGCCCGCCCACAGGATGTG; IGFBP6-R: <br />                                           CTCGGTAGACCTCAGTCTGGAG; PDGF-AA-F: <br />                                           GGGGTCCATGCCACTAAGCATGTGC; PDGF-AA-R: <br />                                           GGAATCTCGTAAATGACCGTCC; M-CSF1-R-F: CAGGAAGGTGATGTCCATCAGC; <br />                                           M-CSF1-R-R: CCAGCTCTGCAGGCACCAG. measurements performed                                           triplicate standardized levels GAPDH. Sequences qPCR primer pairs                                            5&#226;&#8364;&#178;-3&#226;&#8364;&#178; direction) flies follows: Rp49-F: ACAGGCCCAAGATCGTGAAGA; <br />                                           Rp49-R: CGCACTCTGTTGTCGATACCCT; Tubulin-F: AGACCTACTGCATCGACAAC; <br />                                           Tubulin-R: GACAAGATGGTTCAGGTCAC; Yki-F: GCGCCTTGCCGCCGGGATG; Yki- <br />                                           R: GCTGGCGATATTGGATTCTG; Grk-F: CTGTTGCGACGCCAAATTG; Grk-R: <br />                                           CCGATTGTCCACCACTAGGAAA; Krn-F: CTGCATTGCCACATTCCCA; Krn-R: <br />                                           CGGTAGGTAAGCGCCGATTAA; Spi-F: AGGAACTGCAGCAGGAATACGA; Spi-R: <br />  <br />  <br />  <br />                                                Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                                              Page 7 <br />  <br />  <br />                                           AGCTTGCGCTCCAGAATGACT; Vn-F: ATCAAGCATGGAAAGAAGCTGC; Vn-R: <br />                                           CGCTTGCGATTGATGGACTT <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Chromatin Immunoprecipitation (ChIP) <br />                                           Assays performed previously described 30. Briefly, MCF10A cells transduced                                           YAP-S127A retrovirus cross-linked, lysed, sonicated generate DNA fragments <br />                                           average size 0.5 kb. immunoprecipitation performed using 1 &#206;&#188;g antibody <br />                                           IgG YAP (Santa Cruz, CA), respectively. Sequences ChIP PCR primers  5&#226;&#8364;&#178;-3&#226;&#8364;&#178; <br />                                           direction)  AREG-F: CCAAAAGAATCTTTTGAAATCTTTGGGC; AREG-R: <br />                                           GTGAGGGTATGACCAAGTATGGGAAATAAG. Sequences CTGF PCR primers <br />                                           previously reported 14. <br />  <br />                               Drosophila Genetic Analyses <br />                                           flies maintained standard cornmeal-agar-molasses medium, w1118 flies                                           used control. test genetic modification yki+ expression phenotype,                                           established w&#226;&#710;&#8217;; GMR-Gal4/CyO; UAS-yki+/TM6B stock combining GMR-Gal4 <br />                                           chromosome UAS-yki+. female virgins (w&#226;&#710;&#8217;;GMR-Gal4/CyO; UAS-yki+/TM6B) <br />                                           crossed males different EGFR signaling mutant alleles (obtained                                           Bloomington Drosophila Stock Center, Table S1). crosses cultured 25&#194;&#176;C <br />                                           resulting female progenies balancer chromosomes  genotypes                                           w&#226;&#710;&#8217;; GMR-Gal4/mutant; UAS-yki+/+ w&#226;&#710;&#8217;;GMR-Gal4/+; UAS-yki+/mutant) analyzed <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           presented Figure S3 Table S1. test potential interactions hpo wts,                                           performed similar genetic crosses using GMR-hpo+/CyO GMR-wts+/CyO stocks Figure <br />                                           5 Table S1.. <br />  <br />                                           Immunoblotting dpERK performed dissecting wing imaginal discs                                           instar larvae control (w1118 nubbin-Gal4/UAS-YAPS127A. qRT-PCR analysis Egfr <br />                                           ligands carried using eye discs control (w1118 YkiS168A expression <br />                                           larvae (genotype: yw eyFlp/+; tub&gt;w+&gt;ykiSA/+). Following standard protocols                                           western blot qRT-PCR. Primers qRT-PCR listed previous section. <br />  <br />                               Supplementary Material <br />                                           Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                           thank Drs Duojia Pan, Max Frolov, G Halder, Zhichun Lai generously sharing Drosophila stocks used                                           work. appreciate discussions Drs Julie Wells, Fajun Yang Tianyi Zhang thank Fowle NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           assistance electron microscopy. work supported National Institutes Health (NIH) grant R01 <br />                                           95281, Doris Duke Foundation Distinguished Clinical Investigator Award, National Foundation Cancer <br />                                           Research grant Howard Hughes Medical Institute  D H.); NIH grants CA080111 CA089393                                           Breast Cancer Research Foundation  J.S.B.); NIH T32 training grants CA09361-27  J ) CA09361  M.O.); <br />                                           NIH grants F32 CA117737  G S.); NIH grants GM81607 GM053203 Saltonstall Foundation                                            N.J.D.); Tosteson postdoctoral Fellowship  J.Y.J.). <br />  <br />  <br />                               REFERENCES <br />                                           1. Harvey K, Tapon N. Salvador-Warts-Hippo pathway - emerging tumour-suppressor network. <br />                                              Nat Rev Cancer 2007;7:182&#226;&#8364;&#8220;91. [PubMed: 17318211] <br />                                           2. Pan D. Hippo signaling organ size control. Genes Dev 2007;21:886&#226;&#8364;&#8220;97. [PubMed: 17437995] <br />                                           3. Saucedo LJ, Edgar BA. Filling Hippo pathway. Nat Rev Mol Cell Biol 2007;8:613&#226;&#8364;&#8220;21. <br />                                              [PubMed: 17622252] <br />  <br />  <br />  <br />  <br />                                                  Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                                    Page 8 <br />  <br />  <br />                                           4. Camargo FD, et al. YAP1 Increases Organ Size Expands Undifferentiated Progenitor Cells. Curr <br />                                              Biol 2007;17:2054&#226;&#8364;&#8220;60. [PubMed: 17980593] <br />                                           5. Dong J, et al. Elucidation universal size-control mechanism Drosophila mammals. Cell <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              2007;130:1120&#226;&#8364;&#8220;33. [PubMed: 17889654] <br />                                           6. Hao Y, Chun  Cheung K, Rashidi B, Yang X. Tumor suppressor LATS1 negative regulator                                              oncogene YAP. J Biol Chem 2008;283:5496&#226;&#8364;&#8220;509. [PubMed: 18158288] <br />                                           7. Overholtzer M, et al. Transforming properties YAP, candidate oncogene chromosome 11q22 <br />                                              amplicon. Proc Natl Acad Sci U S 2006;103:12405&#226;&#8364;&#8220;10. [PubMed: 16894141] <br />                                           8. Zender L, et al. Identification validation oncogenes liver cancer using integrative <br />                                              oncogenomic approach. Cell 2006;125:1253&#226;&#8364;&#8220;67. [PubMed: 16814713] <br />                                           9. Zhang J, Smolen GA, Haber DA. Negative regulation YAP LATS1 underscores evolutionary <br />                                              conservation Drosophila Hippo pathway. Cancer Res 2008;68:2789&#226;&#8364;&#8220;94. [PubMed: 18413746] <br />                                           10. Zhao B, et al. Inactivation YAP oncoprotein Hippo pathway involved cell contact <br />                                               inhibition tissue growth control. Genes Dev 2007;21:2747&#226;&#8364;&#8220;61. [PubMed: 17974916] <br />                                           11. Hanahan D, Weinberg RA. hallmarks cancer. Cell 2000;100:57&#226;&#8364;&#8220;70. [PubMed: 10647931] <br />                                           12. Soule HD, et al. Isolation characterization spontaneously immortalized human breast <br />                                               epithelial cell line, MCF-10. Cancer Res 1990;50:6075&#226;&#8364;&#8220;86. [PubMed: 1975513] <br />                                           13. McAllister SS, et al. Systemic endocrine instigation indolent tumor growth requires osteopontin. <br />                                               Cell 2008;133:994&#226;&#8364;&#8220;1005. [PubMed: 18555776] <br />                                           14. Zhao B, et al. TEAD mediates YAP-dependent gene induction growth control. Genes Dev. 2008 <br />                                           15. Willmarth NE, Ethier SP. Autocrine juxtacrine effects amphiregulin proliferative, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               invasive, migratory properties normal neoplastic human mammary epithelial cells. J Biol <br />                                               Chem 2006;281:37728&#226;&#8364;&#8220;37. [PubMed: 17035230] <br />                                           16. Tapon N, et al. salvador Promotes cell cycle exit apoptosis Drosophila mutated                                               human cancer cell lines. Cell 2002;110:467&#226;&#8364;&#8220;78. [PubMed: 12202036] <br />                                           17. Shilo BZ. Regulating dynamics EGF receptor signaling space time. Development <br />                                               2005;132:4017&#226;&#8364;&#8220;27. [PubMed: 16123311] <br />                                           18. Wu S, Huang J, Dong J, Pan D. hippo encodes Ste-20 family protein kinase restricts cell <br />                                               proliferation promotes apoptosis conjunction salvador warts. Cell 2003;114:445&#226;&#8364;&#8220;56. <br />                                               [PubMed: 12941273] <br />                                           19. Huang J, Wu S, Barrera J, Matthews K, Pan D. Hippo signaling pathway coordinately regulates <br />                                               cell proliferation apoptosis inactivating Yorkie, Drosophila Homolog YAP. Cell <br />                                               2005;122:421&#226;&#8364;&#8220;34. [PubMed: 16096061] <br />                                           20. Cho E, et al. Delineation Fat tumor suppressor pathway. Nat Genet 2006;38:1142&#226;&#8364;&#8220;50. [PubMed: <br />                                               16980976] <br />                                           21. Mao Y, et al. Dachs: unconventional myosin functions downstream Fat regulate growth, <br />                                               affinity gene expression Drosophila. Development 2006;133:2539&#226;&#8364;&#8220;51. [PubMed: 16735478] <br />                                           22. Garoia F, et al. tumor suppressor gene fat modulates EGFR-mediated proliferation control <br />                                               imaginal tissues Drosophila melanogaster. Mech Dev 2005;122:175&#226;&#8364;&#8220;87. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               15652705] <br />                                           23. Zhao B, Lei QY, Guan KL. Hippo-YAP pathway: new connections regulation organ <br />                                               size cancer. Curr Opin Cell Biol 2008;20:638&#226;&#8364;&#8220;46. [PubMed: 18955139] <br />                                           24. Berquin IM, Dziubinski ML, Nolan GP, Ethier SP. functional screen genes inducing epidermal <br />                                               growth factor autonomy human mammary epithelial cells confirms role amphiregulin. <br />                                               Oncogene 2001;20:4019&#226;&#8364;&#8220;28. [PubMed: 11494130] <br />                                           25. Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding breast cancer. J Clin <br />                                               Invest 2007;117:337&#226;&#8364;&#8220;45. [PubMed: 17218988] <br />                                           26. Streicher KL, et al. Activation nuclear factor kappaB/interleukin-1 positive feedback loop                                               amphiregulin human breast cancer cells. Mol Cancer Res 2007;5:847&#226;&#8364;&#8220;61. [PubMed: 17670913] <br />                                           27. Berasain C, et al. Novel role amphiregulin protection liver injury. J Biol Chem <br />                                               2005;280:19012&#226;&#8364;&#8220;20. [PubMed: 15753092] <br />                                           28. McBryan J, Howlin J, Napoletano S, Martin F. Amphiregulin: role mammary gland development <br />                                               breast cancer. J Mammary Gland Biol Neoplasia 2008;13:159&#226;&#8364;&#8220;69. [PubMed: 18398673] <br />  <br />  <br />                                                 Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                                 Page 9 <br />  <br />  <br />                                           29. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis oncogenesis MCF-10A mammary <br />                                               epithelial acini grown dimensional basement membrane cultures. Methods 2003;30:256&#226;&#8364;&#8220;68. <br />                                               [PubMed: 12798140] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           30. Wells J, Farnham PJ. Characterizing transcription factor binding sites using <span id='am-19' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-20' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span>formaldehyde</span> <br />                                               crosslinking immunoprecipitation. Methods 2002;26:48&#226;&#8364;&#8220;56. [PubMed: 12054904] <br />                                           31. Gabay L, Seger R, Shilo BZ. situ activation pattern Drosophila EGF receptor pathway                                               development. Science 1997;277:1103&#226;&#8364;&#8220;6. [PubMed: 9262480] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                       Page 10 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 1. YAP-induced secreted factor enhances EGF-independent growth MCF10A cells <br />                                             Non-cell-autonomous effect YAP. Vector (tagged Cherry marker) YAP- <br />                                           Wt YAP-S127A (tagged GFP) transduced MCF10A cells cultured Matrigel <br />                                           separately 1:1 mixture 25 days EGF. Representative light                                           fluorescence images shown. (Scale bars, 100&#206;&#188;m) (b) YAP YAP-S127A promote <br />                                           EGF-independent growth MCF10A cells 3D culture. Cells transduced vector, <br />                                           YAP YAP-S127A cultured Matrigel 25 days absence EGF. <br />                                           Representative phase contrast images shown. (Scale bars, 100&#206;&#188;m) Immunoblotting analysis <br />                                           endogenous exogenous YAP, using antibodies detect Flag-tag, YAP                                           phosphorylated S127 residue mutated YAP-S127A. &#206;&#178;-Tubulin used loading <br />                                           control. (c) YAP-Wt YAP-S127A conditioned media induce EGF-independent growth <br />                                           parental MCF10A cells 3D culture. Equal numbers MCF10A cells plated                                           Matrigel fed 25 days medium vector, YAP YAP-S127A transduced 3D <br />                                           cultures. Representative phase contrast images shown. Numbers represent total acini NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           culture +/&#226;&#710;&#8217; SD  200X fields). (Scale bars, 100&#206;&#188;m) <br />  <br />  <br />  <br />  <br />                                                Nat Cell Biol. Author manuscript; available PMC 2010 June 1. <br />                             Zhang et al.                                                                                          Page 11 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 2. Amphiregulin (AREG) mediates YAP-induced EGF-independent growth <br />                                             Secreted growth factor screen. Human Growth Factor Antibody Array analysis <br />                                           (RayBiotech, Norcross, GA) performed using 25th day conditioned medium                                           vector YAP-S127A transduced cells grown presence (left) absence (right) EGF. <br />                                           membrane encoded antibodies 41 growth factors receptors,                                           positive negative controls upper left corner. proteins predominantly <br />               <br /> </body></html>